Ignite Creation Date:
2024-05-06 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03555877
Status:
COMPLETED
Last Update Posted:
2023-07-07
First Post:
2018-02-16
Brief Title:
Anti-hormonal Therapie With Ribociclib in HR-positive HER2- Negative Metastatic Breast Cancer
Sponsor:
German Breast Group
Organization:
German Breast Group